Viyash Scientific Limited (BOM:512529)
India · Delayed Price · Currency is INR 265.40
+4.85 (1.86%)
At close: Sep 4, 2026
Viyash Scientific Market Cap
Viyash Scientific has a market cap or net worth of 115.84 billion as of September 4, 2026. Its market cap has increased by 162.68% in one year.
Market Cap
115.84B
Enterprise Value
120.18B
Revenue
35.75B
Ranking
n/a
PE Ratio
55.90
Stock Price
265.40
ChartMarket Cap Chart
Since January 5, 2005, Viyash Scientific's market cap has increased from 347.75M to 115.84B, an increase of 33,210.51%. That is a compound annual growth rate of 30.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 115.84B | 27.72% |
| Dec 31, 2025 | 90.70B | 106.22% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Caplin Point Laboratories | 213.61B |
| Granules India | 210.03B |
| AstraZeneca Pharma India | 173.27B |
| Jubilant Pharmova | 146.31B |
| Procter & Gamble Health | 93.92B |
| Sanofi India | 72.55B |
| Bliss GVS Pharma | 71.07B |
| Morepen Laboratories | 62.30B |